Ibugan

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ibugan

Quick Facts

Property Description
Active ingredient Ibuprofen
Form Tablet, capsule, oral suspension, suppository
Pharmacological class Nonsteroidal Anti-Inflammatory Drug (NSAID)
Common use Symptomatic relief of pain, inflammation, and fever
Origin Synthetic compound (Propionic acid derivative)

What Type of Medicine is Ibugan?

Ibugan is a pharmaceutical preparation whose active substance is Ibuprofen, officially classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). Ibuprofen is a synthetic compound derived from propionic acid. Ibugan is defined as a single-ingredient product, containing only Ibuprofen as its main therapeutic agent to address pain and inflammation. The brand is typically positioned for the general population, including specific formulations targeted toward children, and is recognized for its inclusion in essential medicine lists. This brand distinction ensures targeted relief for various patient groups across its primary therapeutic actions.

Ibuprofen: Composition, Forms, and General Purpose

The final composition of Ibugan involves the active compound Ibuprofen combined with necessary pharmaceutical excipients appropriate for its delivery. The medication is manufactured in various dosage forms, including standard oral tablets and capsules, as well as the specialized oral suspension often used for pediatric administration, and suppositories. The general purpose of Ibugan is to provide symptomatic relief through its triple action: it is an analgesic (pain relief), an antipyretic (fever reduction), and an anti-inflammatory agent (swelling reduction). This core functionality relates to the medicine’s effectiveness against common symptoms like mild headache or muscular pain. Ibuprofen has an established use for reducing inflammation and relieving pain, which characterizes its role in basic symptomatic management.

Regulatory References

  1. WHO Essential Medicines Lists
  2. MedlinePlus Drug Information

What side effects are possible with Ibugan?

Possible Side Effects and Safety Information

The safety profile of Ibugan, which contains Ibuprofen, is characterized by adverse reactions classified by frequency and affected organ system, following official regulatory standards for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).

Side effects are most commonly reported in the Gastrointestinal (GI) System and include dyspepsia, abdominal pain, and nausea, which are typically classified as Common. Uncommon reactions often extend to other GI disturbances (diarrhea, vomiting) and include effects on the Skin and Subcutaneous Tissue (rashes) and the Nervous System (headache, insomnia).

Serious Adverse Reactions and Safety Constraints

Official labeling documents serious, Very Rare adverse reactions. These include the development of gastrointestinal ulcers, perforation, or bleeding. Furthermore, an association with a small increased risk of arterial thrombotic events, such as myocardial infarction (heart attack) or stroke, is documented, particularly with high doses and long-term use.

Safety constraints are defined for specific populations and circumstances. Older adults are noted to be at an increased risk of serious consequences from GI bleeding and perforation. Use is constrained in individuals with severe hepatic impairment or severe renal impairment as defined by regulatory documents. The risk of adverse effects is generally stated to be dose-dependent and the risk of GI bleeding is explicitly noted to be more common at the start of treatment.

Overdose and Emergency Response

Ibugan Overdose and When to Seek Help

The official regulatory documents specify that Ibugan overdose manifestations involve several key physiological systems. Documented clinical signs typically include gastrointestinal effects such as nausea, vomiting, and abdominal pain, alongside central nervous system effects like drowsiness, dizziness, confusion, or seizures. Severe and life-threatening outcomes are noted to potentially include acute renal failure, metabolic acidosis, respiratory depression, and potentially fatal gastrointestinal bleeding or perforation.

Regulatory authorities mandate that individuals must seek immediate medical attention or contact a Poison Control Center following suspected overdose, even if the person currently feels well. Urgent help must be sought immediately if symptoms of serious events are observed, such as chest pain, sudden weakness, or trouble breathing. Management of overdose is defined as strictly symptomatic and supportive, as no specific antidote is available. Hospital monitoring of vital signs is also documented as a required component of care. The official profile notes that elderly patients face a greater risk for severe gastrointestinal complications in overdose scenarios.

Therapeutic Uses of Ibugan

What Ibugan Treats: Main Uses and Benefits

Ibuprofen is commonly used to help with symptoms related to physical discomfort, fever, and inflammatory or irritative states. This may assist with maintaining functional stability during periods of heightened symptoms.

Information is considered relevant in conditions characterized by periods of heightened symptoms, such as those that produce noticeable physiological strain. It is often used during phases when symptoms become more noticeable, like with headache, muscular aches, or discomfort associated with acute or episodic changes.

Ibuprofen may assist with managing symptoms that create noticeable functional stress and is applied in scenarios where short-term symptomatic assistance is needed. Ibuprofen contributes to easing the overall symptom load and may provide supportive relief when symptoms interfere with routine activities.

“Ibuprofen is considered relevant for easing symptoms and may assist with maintaining a sense of stability when symptoms are more noticeable.”

Quick Fact: Relief for Symptoms related to physical discomfort

Regulatory References

  1. NIH MedlinePlus overview on Ibuprofen

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Ibugan — official regulatory information

Ibugan's eligibility profile, based on its active ingredient Ibuprofen, is defined by regulatory agencies across absolute prohibitions and restricted use. The medicine is contraindicated and must not be used by individuals with a history of hypersensitivity to aspirin or other NSAIDs, or by patients with active gastrointestinal bleeding, peptic ulcers, or perforation. Use is also prohibited for patients with severe heart failure, severe renal impairment, or severe hepatic impairment.

Population Group Regulatory Status
Third Trimester Pregnancy Contraindicated (absolute prohibition)
First & Second Trimester Pregnancy Restricted Use (only if clearly necessary)
Infants under 6 Months Not Recommended/Not Established
Older Adults Conditional Use (requires caution due to increased risk)

Standard use is permitted for adults and children above the minimum age/weight threshold. Use requires caution and is restricted in patients with mild-to-moderate renal or hepatic impairment, uncontrolled hypertension, or established cardiovascular disease. Eligibility is strictly determined by these regulatory constraints.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Ibugan (Ibuprofen) interaction data is structured based on official government regulatory documents, focusing on combinations that enhance risk or alter systemic drug levels. Contraindicated combinations explicitly prohibit co-administration with other NSAIDs (including COX-2 inhibitors) and high-dose Acetylsalicylic Acid (Aspirin) above 75 mg daily due to the increased risk of adverse effects, such as gastrointestinal bleeding. Ibuprofen is also contraindicated during the setting of coronary artery bypass graft (CABG) surgery.

Documented Pharmacological Interaction Classes

Interaction Type Examples of Interacting Medicines
Increased Bleeding Risk Oral Anticoagulants (Warfarin), Corticosteroids, SSRIs
Altered Drug Exposure Lithium, Methotrexate, Cardiac Glycosides
Reduced Efficacy/Nephrotoxicity Diuretics, ACE Inhibitors, Ciclosporin

Ibuprofen may increase plasma levels of Lithium and Methotrexate by reducing their clearance, a mechanism documented in regulatory data. The concurrent consumption of alcohol is also associated with an increased risk of gastrointestinal bleeding. Cautions are noted for the elderly and patients with underlying hepatic or renal impairment, where interactions with agents affecting the kidneys become more clinically significant.

Mechanism of Action

Enzyme Blockade in Prostanoid Synthesis

The action of Ibugan involves non-selective, reversible inhibition of the Cyclooxygenase (COX) enzymes, specifically targeting both COX-1 and COX-2 isoforms. This interaction competitively blocks the conversion of arachidonic acid into prostanoids , thereby altering key pathways that synthesize signaling mediators.


Central and Peripheral Signaling Modulation

Ibugan's action reduces the local concentration of sensitizing mediators like Prostaglandin E2 ( PGE2). This effect occurs peripherally at nerve endings (reducing PGE2's role in nociceptive signaling) and centrally within the hypothalamic thermoregulatory center. By modifying these early molecular steps, the mechanism introduces a reduction in mediator levels that influences thermal set point and local tissue responses.

Dosage and Administration Information

Administration Guidelines (Ibuprofen / Hydrocodone-Ibuprofen)

This section outlines the usage instructions for Ibugan and associated combination products.

Dosage and Frequency

Administration Detail Typical Parameters
Route Oral (Tablet, Capsule, Suspension)
Adult Dose (OTC) 200 mg to 400 mg per dose.
Maximum Daily Limit Do not exceed 1200 mg (OTC) or up to 3200 mg (Rx) in 24 hours.
Frequency Every 4 to 6 hours as needed (PRN).

Administration Procedure

  1. Physical Intake: Swallow tablets or capsules whole. Do not crush, break, or chew immediate-release or extended-release forms, especially combination products, to prevent rapid release of medication.
  2. Timing: Ibugan may be taken with food or milk to reduce the risk of stomach irritation; otherwise, it can be taken without regard to meals.
  3. Liquid Preparation: Oral suspension or liquid drops must be shaken well before each use. Use the measuring device provided with the product for accurate dosing.

Population-Specific Constraints

  • Pediatric Use: Dosing for children is typically calculated based on body weight (mg/kg). Use in infants under 6 months is generally not established or recommended without medical guidance.
  • Course Duration: Do not use for self-treatment of pain for more than 10 consecutive days or fever for more than 3 days, unless directed by a healthcare professional. Use the lowest effective dose for the shortest duration necessary.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ibugan


Evidence for Symptomatic Relief of Mild to Moderate Pain (Analgesia)

Ibugan (Ibuprofen) was evaluated in research exploring outcomes related to physical discomfort, particularly in contexts involving fluctuating or unstable symptoms of pain. The primary evidence base consists of a large number of short-term, placebo-controlled Randomized Controlled Trials (RCTs) and comprehensive systematic reviews. These trials primarily measured changes in pain intensity reported by participants over short observation periods, often only a few hours after a single dose.

Studies report how symptoms evolved in the observed populations, detailing measurements of symptom change compared to a sugar pill or active comparator treatments. The evidence base is High-level regarding the study of short-term symptom patterns, but it does not provide comprehensive information regarding the long-term stability during continuous use for chronic or persistent pain issues. The results apply only to the populations studied, which were typically adults and adolescents.


Evidence for Fever Reduction (Antipyretic Action)

The research into Ibugan for fever reduction was evaluated in numerous Randomized Controlled Trials (RCTs), with a significant focus on pediatric populations. The studies focused on outcomes related to systemic or functional imbalance, such as body temperature. Studies report how measurements of temperature evolved during short observation periods. Research highlights changes measured during the study period concerning the duration of temperature change compared to other treatments evaluated in the studies. Inconsistency in optimal dosing strategies has been an area of discussion in the scientific literature, suggesting that evidence quality varies across studies regarding dose-response relationships in certain age groups.


What is Still Uncertain About Ibugan's Research Base

While the evidence base for acute, short-term evaluation is extensive, research highlights areas where certainty remains low or where data are still emerging. Specifically, long-term effects are not fully established regarding the sustained symptomatic observation over periods exceeding a few months of regular use. The comparative evidence is lacking for certain new or alternative treatment methods. Furthermore, the evidence quality varies across studies when analyzing specific doses or formulations, and the subgroup findings are uncertain for specific comorbidity-defined groups.

Key Studies & References Guideline: Management of acute fever in children

Frequently Asked Questions (FAQ)

Common questions about Ibugan (FAQ)


Q: Is Ibugan the same type of medicine as [Common OTC Pain Reliever]?

Ibugan's active ingredient, Ibuprofen, is officially classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). This classification describes how the medicine works in the body. Other common pain relievers, such as acetaminophen, belong to a distinct pharmacological class and affect the body’s signaling processes in a different way.


Q: Is it true that Ibugan might cause stomach issues?

Yes, official regulatory documents list various gastrointestinal effects as common adverse reactions associated with Ibugan. These commonly reported effects include dyspepsia (indigestion), abdominal pain, and nausea.


Q: Is it normal to feel a mild headache when first starting Ibugan?

Official product information lists headache as an uncommon side effect. Side effects are often noted in regulatory data to occur more frequently at the start of treatment, which means a headache at that time is a reported, although uncommon, occurrence.


Q: Can Ibugan make you feel tired or drowsy?

Official regulatory documents indicate that side effects related to the nervous system, such as dizziness and sleepiness (somnolence), are reported with the use of Ibugan.


Q: Can Ibugan affect my ability to drive?

Because the medicine may cause effects like dizziness or sleepiness, regulatory information advises that caution should be exercised before driving or using machines. Official guidance emphasizes that individuals should be aware of how Ibugan affects them before engaging in activities like driving.


Q: Can Ibugan cause changes in mood or behavior?

Official safety information lists certain side effects related to mood and behavior. These reported effects include changes in mood, such as confusion, depression, and nervousness.


Q: Can Ibugan cause sensitivity to the sun?

While the labeling commonly mentions rashes, some official guidance indicates that NSAIDs like Ibugan may be associated with increased sun sensitivity (photosensitivity) reactions. Users are sometimes advised to take appropriate sun protection measures.


Q: What are the typical non-serious side effects of Ibugan?

The effects most often reported are generally considered non-serious. According to official data, these commonly reported effects include symptoms such as headache, dizziness, upset stomach, nausea, and diarrhea.


Q: Is Ibugan suitable for someone with a history of asthma?

Regulatory documents state Ibugan should not be administered to patients with known aspirin-sensitive asthma. It is generally advised to use the medicine with caution in patients who have pre-existing asthma.


Q: Are there any reported interactions between Ibugan and herbal remedies?

Some official safety resources have documented case reports suggesting that Ibugan may interact with certain herbal supplements (like Ginkgo biloba). These interactions could potentially lead to an increased risk of bleeding.


Q: Does Ibugan interact with birth control pills?

Drug interaction resources consistent with official data generally indicate that Ibugan does not interfere with the effectiveness of most combined hormonal birth control pills.


Q: Why do official documents mention certain liver conditions with Ibugan?

Ibugan is primarily metabolized in the liver. Official regulatory documents require caution for use in patients with pre-existing liver impairment because the medicine is associated with rare cases of drug-induced liver injury.


Q: Can Ibugan be used if I have kidney issues?

Official warnings exist because NSAIDs, including Ibugan, act on a mechanism that helps maintain blood flow to the kidneys. Inhibition of this process can reduce blood flow to the kidneys, increasing the risk of acute kidney injury, especially for those with pre-existing kidney issues.


Q: Can taking Ibugan affect fertility?

Regulatory-cited research has suggested that Ibugan may be associated with a reversible reduction in sperm production in men. Research consistent with official guidance has suggested the medicine could potentially affect ovarian development in female fetuses.


Q: What is the difference between the various strengths of Ibugan?

Ibugan is available in both lower OTC doses and higher prescription-only (Rx) doses. The main regulatory distinction is that adverse effects are noted to be dose-dependent, meaning higher doses are associated with greater risk. OTC doses are generally intended for short-term, mild pain management.


Q: How quickly does Ibugan typically start to work?

The product is generally rapidly absorbed after oral administration. Clinical data indicates that maximum concentrations in the plasma, which relates to the onset of action, typically occur within 1 to 2 hours.


Q: What should I do if the expected effects of Ibugan are not happening?

Regulatory patient information suggests that users contact a healthcare professional or pharmacist if the medicine is not relieving the symptoms or if they have other concerns. This allows for a review of the individual situation and dosage.


Q: What happens if I miss a dose of Ibugan?

Patient information leaflets commonly advise that if a dose is forgotten, the person should ensure the recommended time interval between doses is maintained. It is noted that the maximum 24-hour dose must not be exceeded.


Q: What happens if I stop taking Ibugan suddenly?

Regulatory information does not indicate that Ibugan causes physical dependence or withdrawal symptoms. If the medicine is discontinued, the original symptoms (pain or inflammation) for which it was taken may return.


Q: Is Ibugan recommended for long-term or short-term use?

Ibugan is intended for short-term symptomatic relief. The guidance for self-treatment is that it should not exceed 10 consecutive days. Long-term use is associated with an increased risk of serious adverse events.


Q: Is there a generic version of Ibugan available?

Yes, the active ingredient of Ibugan, Ibuprofen, is widely available as a generic medication worldwide. Ibuprofen is included in the World Health Organization's List of Essential Medicines.


Q: Can I buy Ibugan without a prescription in some countries?

The regulatory status of Ibugan (Ibuprofen) varies globally. The medicine is classified as an Over-The-Counter (OTC) medicine in many regions, including the US, Canada, and the UK, and can be purchased without a prescription.


Q: Does Ibugan have any effect on sleep?

Official safety information lists sleeplessness (insomnia) as a reported uncommon side effect. If this or other nervous system effects occur, it may influence sleep patterns.

How should Ibugan be stored and disposed of?

How to Store and Dispose of Ibugan

Official Storage Requirements

Ibugan must be stored at controlled room temperature, typically defined as between 20 C and 25 C (68 F and 77 F), according to regulatory documentation. The product must be protected from excessive heat and moisture and must remain in its original container with the cap tightly closed to maintain its stability and integrity.

Child Safety and Handling

As required by labeling, Ibugan must be kept out of the sight and reach of children. The container seal should not be broken or missing upon initial use.

Disposal Instructions

Unused or expired Ibugan must be disposed of according to local requirements. Official instructions prohibit throwing the medicine away via wastewater or household waste to prevent environmental contamination, consistent with guidelines from health authorities.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ibugan found in:

A-Z Index: